• Home
  • Study Details
By physician referral or invitation only

Pancreatic Cancer with Electron intraoperative Radiation therapy

We want to research how well Intraoperative Radiation therapy during surgery works in treating pancreatic cancer after 3-6 months of chemotherapy and external radiation therapy. This multi-center, phase II study will enroll patients with either borderline-resectable or locally advanced unresectable pancreatic cancer who have already received chemotherapy and radiation therapy. Patients will be stratified for analysis based on the extent of their disease at initial diagnosis. All patients will receive the same protocol-specified intervention of electron beam intraoperative radiation therapy (IORT). IORT will be administered as determined to be best practice by the study doctor. IORT will be administered in 1 day.

Age & Gender

  • 18 years ~ 99 years
  • Male, Female

Contact the Team


Thank you for your interest, but this study is recruiting by invitation only.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Theodore Yanagihara
Radiation Oncology - Chapel Hill

Study Type

Clinical or Medical

Study Topics

Cancer (Pancreatic)

IRB Number




Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.


  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research